Nigellae sativae oleum

As a natural remedy, black cumin oil is said to have immunomodulating, antihistamine, antiseptic, antioxidant, anti-inflammatory, fungicidal, anthelmintic, cytostatic, diuretic, diaphoretic, lactation-promoting, antihypertensive and digestive properties. Black cumin oil is used for allergic diseases, including hay fever, bronchitis, bronchial asthma, whooping cough, skin diseases, including eczema, psoriasis, atopic dermatitis, acne, fungal infections, gastrointestinal complaints, hepatitis, diabetes mellitus, worm diseases, lactation deficiency, cancer and immunodeficiency. Not a drug status, but a dietary supplement!

Studies confirm significant improvements in autoimmune diseases such as rheumatoid arthritis, Hashimoto's thyroiditis, as well as in allergic diseases(bronchial asthma, atopic dermatitis), simultaneous improvement in hypertension, hyperlipidemia, LDL and triglycerides, sugar levels (Chrubasik-Hausmann S. Freiburg).

ESCOP: Not processed

HMPC: Not processed

Commission E: Not processed, is classified as a food supplement, not as a medicinal product.

In studies, a reduced inflammation of the epidermis and dermis, a significant reduction in IL-17 levels could be determined externally by black cumin oil (Vihal S et al. 2025))

Cosmetics industry: contained in cosmetic ointments, also in perfumes.

Commercially available as black cumin oil and black cumin capsules

1. https://www.awl.ch/heilpflanzen/nigella_sativa/schwarzkuemmel.htm
2. Aftab A et al (2013) A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pac J Trop Biomed.3: 337-352
3. Vihal S et al. (2025) Nigella sativa Oil-loaded Ethanolic Vesicular Gel for Imiquimod-induced Plaque Psoriasis: Physicochemical Characterization, Rheological Studies, and In vivo Efficacy. Curr Drug Deliv;22(1):80-91. doi: 10.2174/0115672018246645231019131748. PMID: 38956909.
4. Nasiri N et al. (2022) The Therapeutic Effects of Nigella sativa on Skin Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med. 5;2022:7993579. doi: 10.1155/2022/7993579. PMID: 36518853; PMCID: PMC9744621.
5. Blaschek W (2015) Wichtl-Teedrogens and phytopharmaceuticals. A handbook for practice. Wissenschaftliche Verlagsgesellschaft Munich. S 450-451
6. https://www.uniklinik-freiburg.de/fileadmin/mediapool/08_institute/rechtsmedizin/pdf/Addenda/Schwarzk%C3%BCmmel.pdf